Roger Hayes

发表

Issues facing the bioanalytical community: summary of round table discussions.

Neil Spooner, Stephanie Cape, Roger Hayes, 2016, Bioanalysis.

ADL - An Interface Definition Language for Specifying and Testing Software

Sriram Sankar, Roger Hayes, 1994, Workshop on Interface Definition Languages.

Integrating Emerald into a System for Mixed-Language Programming

Richard D. Schlichting, Roger Hayes, Norman C. Hutchinson, 1990, Comput. Lang..

2 Bioanalytical report writing

Kevin Bateman, Roger Hayes, Eric Woolf, 2022 .

2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1--small molecules by LCMS).

Li Xue, Stacy Ho, Neil Spooner, 2014, Bioanalysis.

The 10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraud.

Stephanie Cape, Roger Hayes, Jennifer Zimmer, 2017, Bioanalysis.

The Designof theSaguaroDistributed Operating System

Roger Hayes, M. Purdin, 1987 .

Facilitating Mixed Language Programming in Distrbuted Systems

Richard D. Schlichting, Roger Hayes, 1987, IEEE Transactions on Software Engineering.

Systematic Networking: A Guide for Personal and Corporate Success

Roger Hayes, 1996 .

How to Load Test e-Commerce Applications

Roger Hayes, 2000, Int. CMG Conference.

Speak freely: Roger Hayes describes how his trust developed protocols which allow staff to speak to the media

Roger Hayes, R. Hayes, 1996 .

The Design of the Saguaro Distributed Operating System

Gregory R. Andrews, Richard D. Schlichting, Roger Hayes, 1987, IEEE Trans. Software Eng..

Specifying and Testing Software Components using ADL

Sriram Sankar, Roger Hayes, R. Hayes, 1994 .

2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity).

Lindsay King, Roger Hayes, Surinder Kaur, 2014, Bioanalysis.

2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 - hybrid LBA/LCMS, ELN & regulatory agencies' input).

Lindsay King, Stacy Ho, Roger Hayes, 2014, Bioanalysis.

The business of bioanalysis: new technology integration into bioanalytical workflows.

Roger Hayes, Scott Summerfield, Afshin Safavi, 2018, Bioanalysis.

A simple system for constructing distributed, mixed‐language programs

Richard D. Schlichting, Roger Hayes, Steve W. Manweiler, 1988, Softw. Pract. Exp..

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 1 - small molecules by LCMS).

Roger Hayes, Amanda Wilson, Eric Woolf, 2015, Bioanalysis.

GCC Consolidated Feedback to ICH on the 2019 ICH M10 Bioanalytical Method Validation Draft Guideline.

Hao Feng, Stephanie Cape, Roger Hayes, 2019, Bioanalysis.

2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMS.

Stacy Ho, Roger Hayes, Eric Woolf, 2013, Bioanalysis.

11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation.

Stephanie Cape, Roger Hayes, Jennifer Zimmer, 2018, Bioanalysis.

Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for Bioanalysis.

Roger Hayes, Zhongping John Lin, Fabio Garofolo, 2011, Bioanalysis.

4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryover.

Roger Hayes, Xinping Fang, Fabio Garofolo, 2012, Bioanalysis.

12th GCC Closed Forum: critical reagents; oligonucleotides; CoA; method transfer; HRMS; flow cytometry; regulatory findings; stability and immunogenicity.

Stephanie Cape, Roger Hayes, Dave Williams, 2019, Bioanalysis.

Recommendations on incurred sample stability (ISS) by GCC.

Stephanie Cape, Roger Hayes, Jennifer Zimmer, 2014, Bioanalysis.

Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC).

Roger Hayes, Xinping Fang, Zhongping John Lin, 2012, Bioanalysis.

8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validation.

Roger Hayes, Jennifer Zimmer, Xinping Fang, 2014, Bioanalysis.

Recommendations on biomarker bioanalytical method validation by GCC.

Roger Hayes, Fabio Garofolo, John Allinson, 2012, Bioanalysis.

Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis.

Stephanie Cape, Roger Hayes, Sumit Kar, 2019, Bioanalysis.

Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars.

Roger Hayes, Jennifer Zimmer, Xinping Fang, 2012, Bioanalysis.

9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooks.

Stephanie Cape, Roger Hayes, Jennifer Zimmer, 2016, Bioanalysis.

Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC).

Roger Hayes, Jennifer Zimmer, Xinping Fang, 2012, Bioanalysis.

7th GCC Insights: incurred samples use; fit-for-purpose validation, solution stability, electronic laboratory notebook and hyperlipidemic matrix testing.

Stephanie Cape, Roger Hayes, Jennifer Zimmer, 2014, Bioanalysis.